Want to join the conversation?
$EA increased FY16 non-GAAP net revenue guidance by $50MM to $4.50Bil, diluted non-GAAP EPS guidance by $0.15 to $3.00 per share and operating cash flow by $50MM to $1.20Bil. For 3Q16, non-GAAP net revenue is expected to be about $1.775Bil and non-GAAP diluted EPS is expected to be approx. $1.75.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?